T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Welltower
WELL
$166B
| $3.12B | 0.34% |
16,826,035
+1,734,922
| +11% | +$324M |
|
52
Southern Company
SO
$106B
| $3B | 0.32% |
34,459,462
+5,436,212
| +19% | +$496M |
|
53
McDonald's
MCD
$195B
| $2.9B | 0.31% |
9,474,749
+277,617
| +3% | +$85M |
|
54
Chevron
CVX
$386B
| $2.88B | 0.31% |
18,887,660
-434,889
| -2% | -$66.2M |
|
55
Palantir
PLTR
$411B
| $2.87B | 0.31% |
16,165,321
+970,070
| +6% | +$176M |
|
56
argenx
ARGX
$54.8B
| $2.83B | 0.3% |
3,362,324
-278,085
| -8% | -$238M |
|
57
Walmart Inc
WMT
$923B
| $2.82B | 0.3% |
25,352,155
-10,936,077
| -30% | -$1.17B |
|
|
XYZ
58
Block Inc
XYZ
$47B
| $2.8B | 0.3% |
43,093,016
-4,937,817
| -10% | -$341M |
|
59
Goldman Sachs
GS
$302B
| $2.77B | 0.3% |
3,149,022
-184,279
| -6% | -$150M |
|
60
Texas Instruments
TXN
$253B
| $2.74B | 0.3% |
15,813,193
+137,735
| +0.9% | +$23.6M |
|
61
American Express
AXP
$232B
| $2.72B | 0.29% |
7,339,507
-3,537
| -0% | -$1.27M |
|
62
TSMC
TSM
$2.23T
| $2.7B | 0.29% |
8,890,155
-2,585,242
| -23% | -$759M |
|
63
Morgan Stanley
MS
$342B
| $2.65B | 0.29% |
14,917,776
+3,364,080
| +29% | +$561M |
|
64
TE Connectivity
TEL
$62B
| $2.64B | 0.28% |
11,604,495
-516,986
| -4% | -$120M |
|
65
Sea Limited
SE
$78.5B
| $2.62B | 0.28% |
20,517,378
+3,531,834
| +21% | +$523M |
|
66
Elevance Health
ELV
$86.6B
| $2.61B | 0.28% |
7,446,185
+1,607,274
| +28% | +$543M |
|
67
Johnson & Johnson
JNJ
$629B
| $2.57B | 0.28% |
12,423,886
+3,655,754
| +42% | +$723M |
|
|
68
CSX Corp
CSX
$92.8B
| $2.55B | 0.28% |
70,428,871
+33,047,720
| +88% | +$1.18B |
|
69
Boeing
BA
$183B
| $2.5B | 0.27% |
11,506,446
-1,979,762
| -15% | -$407M |
|
70
Natera
NTRA
$45.5B
| $2.49B | 0.27% |
10,871,989
-1,075,426
| -9% | -$224M |
|
71
International Paper
IP
$21.8B
| $2.48B | 0.27% |
62,973,983
-3,247,346
| -5% | -$134M |
|
72
Colgate-Palmolive
CL
$73.6B
| $2.46B | 0.27% |
31,187,277
-1,154,744
| -4% | -$90.5M |
|
73
Analog Devices
ADI
$187B
| $2.44B | 0.26% |
9,011,708
-379,992
| -4% | -$95.5M |
|
74
Allstate
ALL
$64.7B
| $2.43B | 0.26% |
11,684,199
-1,255,044
| -10% | -$257M |
|
75
Cencora
COR
$60B
| $2.36B | 0.25% |
6,992,825
-731,075
| -9% | -$249M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.